Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Prospective, Randomized Study on the Efficacy of Iron Therapy Using Intravenous (IV) Iron Supplements Relative to Oral Iron Intake for Increasing Left Ventricular Systolic Function in Patients With Myocardial Infarction

NCT05309499 is registered in ClinicalTrials.gov with Kazan State Medical University as lead sponsor.

NCT NCT05309499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05309499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Prospective, Randomized Study on the Efficacy of Iron Therapy Using Intravenous (IV) Iron Supplements Relative to Oral Iron Intake for Increasing Left Ventricular Systolic Function in Patients With Myocardial Infarction
Lead sponsor
Kazan State Medical University
Phase
Not applicable
Overall status
Completed
Start date
December 5, 2021
Completion date
September 15, 2025
Enrollment
298 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron-deficiency, myocardial infarction